Vaccine trial for respiratory syncytial virus expands
Nearly 20,000 people have participated in the Sincigal clinical trial for respiratory syncytial virus vaccine. The trial is now expanding to include adults over 18 years old.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.